Evercore ISI analyst Gavin Clark-Gartner initiated coverage with a Buy rating on Mirum Pharmaceuticals (MIRM – Research Report) today and ...
Clinical development and trial testing of vesleteplirsen (SRP-5051) for Duchenne muscular dystrophy (DMD) was stopped, with ...
TD Cowen analyst Ritu Baral maintained a Buy rating on ATAI Life Sciences (ATAI – Research Report) yesterday. The company’s shares ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback